371 related articles for article (PubMed ID: 24340665)
1. [Regulatory science research to facilitate the development of cell/tissue-processed products].
Sato Y; Tsutsumi H; Sawada R; Suzuki T; Yasuda S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):16-9. PubMed ID: 24340665
[TBL] [Abstract][Full Text] [Related]
2. [Translational/regulatory science researches of NIHS for regenerative medicine and cellular therapy products].
Sato Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):6-9. PubMed ID: 25707195
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenicity assessment of human cell-processed therapeutic products.
Yasuda S; Sato Y
Biologicals; 2015 Sep; 43(5):416-21. PubMed ID: 26071041
[TBL] [Abstract][Full Text] [Related]
4. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
Azuma K; Yamanaka S
Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
[TBL] [Abstract][Full Text] [Related]
5. Novel paths towards neural cellular products for neurological disorders.
Daadi MM
Regen Med; 2011 Nov; 6(6 Suppl):25-30. PubMed ID: 21999259
[TBL] [Abstract][Full Text] [Related]
6. [Perspectives regarding the potential use of human induced pluripotent stem cells for the development of and research on medicinal products].
Hayakawa T; Mizuguchi H
Brain Nerve; 2012 Jan; 64(1):47-57. PubMed ID: 22223501
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
Chang KA; Lee JH; Suh YH
J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
[TBL] [Abstract][Full Text] [Related]
8. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
Osakada F
Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
[TBL] [Abstract][Full Text] [Related]
9. [Regenerative therapy for post-stroke patients].
Yamashita T; Abe K
Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
[TBL] [Abstract][Full Text] [Related]
10. [An overview of "the guideline for clinical research using human stem cells"].
Matsuyama A
Nihon Rinsho; 2008 May; 66(5):843-9. PubMed ID: 18464500
[TBL] [Abstract][Full Text] [Related]
11. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
Abbasalizadeh S; Baharvand H
Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
[TBL] [Abstract][Full Text] [Related]
12. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells.
Hayakawa T; Aoi T; Umezawa A; Ozawa K; Sato Y; Sawa Y; Matsuyama A; Yamanaka S; Yamato M
Regen Ther; 2015 Dec; 2():95-108. PubMed ID: 31245463
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Toxicity Studies for Regenerative Medicine in Japan.
Shigeto J; Ichiki T; Nii T; Konno K; Nakanishi Y; Sugiyama D
Clin Ther; 2018 Nov; 40(11):1813-1822. PubMed ID: 30458928
[TBL] [Abstract][Full Text] [Related]
14. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
15. [Regenerative medicine: history and perspectives].
Okabayashi K; Asashima M
Nihon Rinsho; 2008 May; 66(5):825-30. PubMed ID: 18464498
[TBL] [Abstract][Full Text] [Related]
16. iPS cell technology in regenerative medicine.
Lengner CJ
Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
[TBL] [Abstract][Full Text] [Related]
17. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of human embryonic stem cells.
Hayakawa T; Aoi T; Umezawa A; Ozawa K; Sato Y; Sawa Y; Matsuyama A; Yamanaka S; Yamato M
Regen Ther; 2015 Dec; 2():109-122. PubMed ID: 31245464
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent stem cells - a review of the current status in neural regeneration.
Paspala SA; Murthy TV; Mahaboob VS; Habeeb MA
Neurol India; 2011; 59(4):558-65. PubMed ID: 21891934
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering and regenerative medicine: role of toxicologic pathologists for an emerging medical technology.
Jayo MJ; Watson DD; Wagner BJ; Bertram TA
Toxicol Pathol; 2008 Jan; 36(1):92-6. PubMed ID: 18337226
[TBL] [Abstract][Full Text] [Related]
20. Stem cells: are we ready for therapy?
Schroeder IS
Methods Mol Biol; 2014; 1213():3-21. PubMed ID: 25173369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
